Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Duke Realty Co. stock logo
DRE
Duke Realty
$48.20
$57.08
$47.12
$66.22
$18.56B0.82.76 million shsN/A
Empowerment & Inclusion Capital I Corp. stock logo
EPWR
Empowerment & Inclusion Capital I
$10.09
$10.06
$9.69
$10.09
$347.93M0.0498,512 shs6,710 shs
FEO
First Trust/abrdn Emerging Opportunity Fund
$9.58
+0.3%
$9.40
$8.35
$14.16
N/AN/A27,706 shs55 shs
Disc Medicine, Inc. stock logo
IRON
Disc Medicine
$27.55
+3.9%
$51.76
$25.60
$77.60
$665.06M0.18420,998 shs368,874 shs
SPQ
Simplify US Equity PLUS QIS ETF
$28.25
+0.8%
$28.46
$25.38
$29.67
$3.53M0.77780 shs1 shs
7 Energy Stocks to Buy and Hold Forever Cover

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Duke Realty Co. stock logo
DRE
Duke Realty
0.00%0.00%0.00%0.00%0.00%
Empowerment & Inclusion Capital I Corp. stock logo
EPWR
Empowerment & Inclusion Capital I
0.00%0.00%0.00%0.00%0.00%
FEO
First Trust/abrdn Emerging Opportunity Fund
0.00%0.00%0.00%0.00%0.00%
Disc Medicine, Inc. stock logo
IRON
Disc Medicine
-2.86%-11.66%-56.02%-58.83%-16.31%
SPQ
Simplify US Equity PLUS QIS ETF
-0.32%+0.94%-2.98%+3.39%+2,801,999,900.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Duke Realty Co. stock logo
DRE
Duke Realty
1.7072 of 5 stars
0.00.02.52.60.01.72.5
Empowerment & Inclusion Capital I Corp. stock logo
EPWR
Empowerment & Inclusion Capital I
N/AN/AN/AN/AN/AN/AN/AN/A
FEO
First Trust/abrdn Emerging Opportunity Fund
N/AN/AN/AN/AN/AN/AN/AN/A
Disc Medicine, Inc. stock logo
IRON
Disc Medicine
2.7491 of 5 stars
4.41.00.00.03.12.50.0
SPQ
Simplify US Equity PLUS QIS ETF
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Duke Realty Co. stock logo
DRE
Duke Realty
N/AN/AN/AN/A
Empowerment & Inclusion Capital I Corp. stock logo
EPWR
Empowerment & Inclusion Capital I
N/AN/AN/AN/A
FEO
First Trust/abrdn Emerging Opportunity Fund
N/AN/AN/AN/A
Disc Medicine, Inc. stock logo
IRON
Disc Medicine
2.86
Moderate Buy$57.29107.93% Upside
SPQ
Simplify US Equity PLUS QIS ETF
N/AN/A$34.1120.76% Upside

Current Analyst Ratings

Latest DRE, IRON, FEO, EPWR, and SPQ Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/8/2024
Disc Medicine, Inc. stock logo
IRON
Disc Medicine
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$71.00 ➝ $73.00
4/2/2024
Disc Medicine, Inc. stock logo
IRON
Disc Medicine
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$75.00 ➝ $40.00
4/2/2024
Disc Medicine, Inc. stock logo
IRON
Disc Medicine
BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$80.00 ➝ $50.00
4/2/2024
Disc Medicine, Inc. stock logo
IRON
Disc Medicine
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$104.00 ➝ $71.00
4/1/2024
Disc Medicine, Inc. stock logo
IRON
Disc Medicine
Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform$84.00 ➝ $43.00
4/1/2024
Disc Medicine, Inc. stock logo
IRON
Disc Medicine
Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingStrong-Buy ➝ Outperform$75.00 ➝ $40.00
4/1/2024
Disc Medicine, Inc. stock logo
IRON
Disc Medicine
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$70.00
3/22/2024
Disc Medicine, Inc. stock logo
IRON
Disc Medicine
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$70.00
3/21/2024
Disc Medicine, Inc. stock logo
IRON
Disc Medicine
Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform$79.00 ➝ $84.00
2/29/2024
Disc Medicine, Inc. stock logo
IRON
Disc Medicine
BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$70.00 ➝ $80.00
(Data available from 4/26/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Duke Realty Co. stock logo
DRE
Duke Realty
$1.11B16.78$3.22 per share14.99$16.12 per share2.99
Empowerment & Inclusion Capital I Corp. stock logo
EPWR
Empowerment & Inclusion Capital I
N/AN/AN/AN/A($0.59) per shareN/A
FEO
First Trust/abrdn Emerging Opportunity Fund
N/AN/AN/AN/AN/AN/A
Disc Medicine, Inc. stock logo
IRON
Disc Medicine
N/AN/AN/AN/A$14.30 per shareN/A
SPQ
Simplify US Equity PLUS QIS ETF
N/AN/AN/AN/AN/AN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Duke Realty Co. stock logo
DRE
Duke Realty
$852.90M$2.4919.3622.633.2285.63%15.66%9.29%N/A
Empowerment & Inclusion Capital I Corp. stock logo
EPWR
Empowerment & Inclusion Capital I
N/AN/A0.00N/AN/A-83.63%4.20%N/A
FEO
First Trust/abrdn Emerging Opportunity Fund
N/AN/A0.00N/AN/AN/AN/AN/A
Disc Medicine, Inc. stock logo
IRON
Disc Medicine
-$76.43M-$3.49N/AN/AN/AN/A-23.37%-22.27%5/20/2024 (Estimated)
SPQ
Simplify US Equity PLUS QIS ETF
N/AN/A0.00N/AN/AN/AN/AN/A

Latest DRE, IRON, FEO, EPWR, and SPQ Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/21/2024Q4 2023
Disc Medicine, Inc. stock logo
IRON
Disc Medicine
-$0.75-$0.97-$0.22-$0.97N/AN/A

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Duke Realty Co. stock logo
DRE
Duke Realty
$1.122.32%N/A44.98%N/A
Empowerment & Inclusion Capital I Corp. stock logo
EPWR
Empowerment & Inclusion Capital I
N/AN/AN/AN/AN/A
FEO
First Trust/abrdn Emerging Opportunity Fund
$1.4014.61%N/AN/AN/A
Disc Medicine, Inc. stock logo
IRON
Disc Medicine
N/AN/AN/AN/AN/A
SPQ
Simplify US Equity PLUS QIS ETF
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Duke Realty Co. stock logo
DRE
Duke Realty
0.61
1.23
1.23
Empowerment & Inclusion Capital I Corp. stock logo
EPWR
Empowerment & Inclusion Capital I
N/A
0.83
0.83
FEO
First Trust/abrdn Emerging Opportunity Fund
N/AN/AN/A
Disc Medicine, Inc. stock logo
IRON
Disc Medicine
N/A
17.06
17.06
SPQ
Simplify US Equity PLUS QIS ETF
N/AN/AN/A

Ownership

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Duke Realty Co. stock logo
DRE
Duke Realty
340384.99 million383.30 millionOptionable
Empowerment & Inclusion Capital I Corp. stock logo
EPWR
Empowerment & Inclusion Capital I
2,02034.50 million32.64 millionNot Optionable
FEO
First Trust/abrdn Emerging Opportunity Fund
N/AN/AN/ANot Optionable
Disc Medicine, Inc. stock logo
IRON
Disc Medicine
7424.14 million23.00 millionNot Optionable
SPQ
Simplify US Equity PLUS QIS ETF
N/A125,001N/AN/A

DRE, IRON, FEO, EPWR, and SPQ Headlines

No headlines for this company have been tracked by MarketBeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Duke Realty logo

Duke Realty

NYSE:DRE
Duke Realty Corporation owns and operates approximately 159 million rentable square feet of industrial assets in 20 major logistics markets. Duke Realty Corporation is publicly traded on the NYSE under the symbol DRE and is a member of the S&P 500 Index.
Empowerment & Inclusion Capital I logo

Empowerment & Inclusion Capital I

NYSE:EPWR
Empowerment & Inclusion Capital I Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other similar business combination with one or more businesses. The company was incorporated in 1999 and is based in New York, New York.

First Trust/abrdn Emerging Opportunity Fund

NYSE:FEO
First Trust-abrdn Emerging Opportunity Fund is a closed-ended balanced mutual fund launched and managed by First Trust Advisors L.P. It is co-managed by Aberdeen Asset Management Inc. The fund invests in public equity and fixed income markets of global emerging countries. It seeks to invest in the stocks of companies operating across the diversified sectors. For its fixed income component, the fund invests in government debt securities, corporate bonds, non investment-grade securities, asset-backed securities, credit-linked notes, and credit default swaps. It employs fundamental analysis to create its portfolio. The fund benchmarks the performance of its portfolio against the Barclays Capital Global Emerging Markets Index, FTSE All World Emerging Market Index, and a blended index composed of JPMorgan Emerging Markets Bond Index - Global Diversified (32.5%); JPMorgan Government Bond Index - Emerging Markets (32.5%); MSCI Global Emerging Markets Index (35.0%). First Trust-abrdn Emerging Opportunity Fund was formed on August 28, 2006 and is domiciled in the United States.
Disc Medicine logo

Disc Medicine

NASDAQ:IRON
Disc Medicine, Inc., together with its subsidiaries, a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases in the United States. The company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, primarily heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for the treatment of erythropoietic porphyrias, including erythropoietic protoporphyria, X-linked protoporphyria, and diamond-blackfan anemia; DISC-0974 for the treatment of anemia of myelofibrosis, and anemia of chronic kidney disease; and DISC-3405 for the treatment of polycythemia vera, and other hematologic disorders. The company's preclinical programs include DISC-0998, for the treatment of anemia associated with inflammatory diseases. Disc Medicine, Inc. was founded in 2017 and is headquartered in Watertown, Massachusetts.

Simplify US Equity PLUS QIS ETF

NYSEARCA:SPQ
The Simplify US Equity PLUS QIS ETF (SPQ) is an exchange-traded fund that mostly invests in total market equity. The fund is an actively managed fund seeking to achieve long-term capital appreciation. The fund combines core US equities with alternative exposure to multiple quantitative investment strategies, attempting to enhance both absolute and risk-adjusted returns. SPQ was launched on Nov 13, 2023 and is issued by Simplify.